Crédit Lyonnais Private Equity offers investment to a diverse range of companies in France.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jan 12, 2005
Biolipox
|
Series C | $41M | Biopharma | — |
Jun 24, 2004
Emulation and Verification Engineering
|
Series Unknown | $7.20M | Electronics | — |
Mar 8, 2004
CareX SA
|
Series B | $32M | Biotechnology | — |
Dec 31, 2003
DiBcom
|
Series Unknown | $13.30M | Developer Platform | — |
Nov 13, 2003
Esmertec AG
|
Series C | €23M | Embedded Systems | — |
Crédit Lyonnais Private Equity has had 8 exits. Crédit Lyonnais Private Equity most notable exits include Eptica , Emulation and Verification Engineering
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Oct 22, 2019 | Eptica | M&A | Customer Service | Detail |
Oct 4, 2012 | Emulation and Verification Engineering | M&A | Electronics | Detail |
Apr 25, 2012 | Envivio | M&A | Broadcasting | Detail |
Jul 29, 2011 | DiBcom | M&A | Developer Platform | Detail |
Nov 23, 2007 | Biolipox | M&A | Biopharma | Detail |